ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Phoenix, AZ, USA:

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies

Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or Other CA19-9 Positive Malignancies....

Active, not recruiting
Pancreatic Cancer
Drug: gemcitabine + nab-paclitaxel
Drug: MVT-5873

Phase 1

BioNTech
BioNTech

Scottsdale, Arizona, United States and 4 other locations

drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy....

Active, not recruiting
Pancreas Cancer
Drug: Sorafenib
Drug: Vemurafenib

Phase 2

HonorHealth Research Institute

Scottsdale, Arizona, United States

This study will evaluate the safety and tolerability of escalating doses of L-DOS47 in combination with doxorubicin, as well as preliminary anti-tumor...

Active, not recruiting
Pancreas Cancer
Biological: L-DOS47
Drug: Doxorubicin

Phase 1, Phase 2

Helix BioPharma

Scottsdale, Arizona, United States and 2 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Other: Placebo

Phase 2

Walid Shaib, MD

Scottsdale, Arizona, United States and 7 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Goodyear, Arizona, United States and 22 other locations

This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...

Active, not recruiting
Advanced Pancreatic Carcinoma
Drug: HCW9218

Phase 1, Phase 2

HCW Biologics

Scottsdale, Arizona, United States and 4 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Scottsdale, Arizona, United States and 35 other locations

PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...

Enrolling
Solid Tumor
Breast Cancer
Drug: SON-DP

Phase 1

Qurgen

Gilbert, Arizona, United States and 4 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Enrolling
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen
Seagen

Phoenix, Arizona, United States and 21 other locations

The goal of this study is to test A2B530,an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorect ...

Enrolling
Solid Tumor
Non Small Cell Lung Cancer Recurrent
Biological: A2B530
Diagnostic Test: xT-Onco with HLA-LOH Assay

Phase 1, Phase 2

A2 Biotherapeutics

Gilbert, Arizona, United States of America and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems